Table 1.
ZIKV n = 1070 | DENV-2 n = 312 | DENV-3 n = 260 | |
---|---|---|---|
Participant characteristics | |||
Age in years, median (range)a | 28 (0.08–88) | 25 (0.5–81) | 24 (0–84) |
Female sex, n (%)b | 623 (58.2) | 127 (40.8) | 129 (49.6) |
Pregnant, n (%) | 49 (4.6) | 5 (1.6) | 5 (1.9) |
Hospitalized, n (%) | 18 (1.7) | 158 (50.6) | 114 (43.8) |
Day post-illness onset of specimen collection, n (%) | |||
0 | 89 (8.3) | 0c | 0c |
1 | 332 (31.0) | 60 (19.2) | 55 (21.2) |
2 | 294 (27.4) | 63 (20.2) | 77 (30.0) |
3 | 245 (22.9) | 84 (26.8) | 62 (23.9) |
4 | 110 (10.3) | 66 (21.0) | 39 (15.1) |
5 | 0c | 39 (12.4) | 27 (10.4) |
Serostatus | |||
Primary, n (%) | 143 (13.4) | 39 (12.4) | 116 (44.8) |
Secondary, n (%) | 927 (86.6) | 274 (87.8) | 144 (55.4) |
Abrreviations: DENV, dengue virus; ZIKV, Zika virus.
aAge was unavailable for 6 and 3 patients infected with DENV-2 and DENV-3, respectively.
bSex was unavailable for 1 patient infected with DENV-2.
cExcluded from analysis.